The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,106.00
Bid: 3,104.00
Ask: 3,108.00
Change: 0.00 (0.00%)
Spread: 4.00 (0.129%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3,106.00
BNZL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

26 Apr 2023 07:00

RNS Number : 4284X
Bunzl PLC
26 April 2023
 

 

26 April 2023

BUNZL Q1 TRADING STATEMENT

 

Bunzl plc, the specialist international distribution and services Group, today announces its trading statement for the period since 31 December 2022.

 

Bunzl's diversified business model has delivered resilient growth, with Group revenue in the first quarter up 8.4% at actual exchange rates and 1.2% at constant exchange rates. At constant exchange rates, organic growth of 0.6% was driven by underlying revenue growth of 1.5%, partially offset by a negative trading day impact of 0.9%. Underlying revenue growth benefitted from continued inflation support but was impacted by the expected decline in Covid-19 related sales. Acquisitions contributed further growth of 2.7% at constant exchange rates, whilst the disposal of our UK healthcare business impacted revenue by 2.1%. Adjusted operating margin over the quarter was slightly ahead of expectations.

 

Underlying revenue growth in Continental Europe and UK & Ireland continued to be supported by very strong product cost inflation. Underlying revenue growth in North America, whilst benefitting from continued product cost inflation, was impacted by volume softness in our foodservice sector, some of which is anticipated to be temporary. Rest of the World was impacted by the decline in Covid-19 related sales, including the non-repeat of some larger orders made during the first quarter of last year.

 

While we see continued uncertainty relating to the macroeconomic environment, at constant exchange rates the Group continues to expect revenue in 2023 to be slightly higher than in 2022, driven by both organic growth and announced acquisitions, and partially offset by a small impact from the UK healthcare disposal. We expect Group adjusted operating profit to be resilient, with operating margin slightly higher than historical levels.

 

In April 2023, Bunzl entered into an agreement to acquire Dimasa, a distributor of cleaning and hygiene products in the Andalusia region of Spain. The business generated revenue of EUR 4 million (c.£3 million) in 2022. Since the start of the year, Bunzl has also completed the acquisitions of Arbeitsschutz-Express in Germany and Capital Paper in Canada.

 

Commenting on today's announcement, Frank van Zanten, Chief Executive Officer of Bunzl, said:

 

"Our performance over the quarter continues to demonstrate the resilience of the Bunzl business model and its strategy. I am also pleased to welcome Dimasa to the Bunzl family. This business is a leading distributor in Southern Spain and strengthens our presence in this region. Our pipeline is active and our balance sheet remains strong, and we see significant opportunities for further acquisition growth to supplement our resilient organic growth."

 

Insight event:

On 29 June 2023, Bunzl will be holding a second insight event for investors, with a focus on our North America Business Area. The virtual event will be hosted by Jim McCool, our CEO of North America. The event will be live from 3pm - 4.15pm BST and will include a Q&A session. Registration details will be made available on our website (www.bunzl.com) ahead of the event.

 

 

Enquiries:

 

Bunzl plc

Frank van Zanten, Chief Executive Officer

Richard Howes, Chief Financial Officer

Sunita Entwisle, Head of Investor Relations

Tel: +44 (0)20 7725 5000

Teneo

Martin Robinson

Olivia Peters

Tel: +44 (0)20 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBUGDSDBDDGXU
Date   Source Headline
2nd May 20242:00 pmRNSDirector/PDMR Shareholding
2nd May 20248:00 amRNSAdditional Listing
1st May 20245:00 pmRNSDirector/PDMR Shareholding
1st May 202410:00 amRNSBlock listing Interim Review
1st May 20249:18 amRNSTotal Voting Rights
25th Apr 20244:45 pmRNSDirector/PDMR Shareholding
24th Apr 20242:51 pmRNSResult of AGM
24th Apr 20247:00 amRNSTrading Statement
22nd Apr 20244:36 pmRNSDirector/PDMR Shareholding
18th Apr 20248:00 amRNSAdditional Listing
11th Apr 20248:00 amRNSAdditional Listing
3rd Apr 20245:28 pmRNSDirector/PDMR Shareholding
3rd Apr 20249:09 amRNSDirector/PDMR Shareholding
2nd Apr 20241:50 pmRNSTotal Voting Rights
21st Mar 20248:00 amRNSAdditional Listing
15th Mar 20243:28 pmRNSAnnual Financial Report
7th Mar 20248:00 amRNSAdditional Listing
5th Mar 20245:05 pmRNSDirector/PDMR Shareholding
4th Mar 20243:03 pmRNSDirector/PDMR Shareholding
1st Mar 202411:35 amRNSTotal Voting Rights
28th Feb 20243:17 pmRNSDirector/PDMR Shareholding
27th Feb 20245:26 pmRNSDirector/PDMR Shareholding
26th Feb 202410:30 amRNSDividend Declaration
26th Feb 20247:00 amRNSFinal Results
26th Feb 20247:00 amRNSAcquisition
5th Feb 20242:20 pmRNSDirector/PDMR Shareholding
1st Feb 20245:08 pmRNSTotal Voting Rights
12th Jan 20244:54 pmRNSDirector/PDMR Shareholding
11th Jan 20243:50 pmRNSDirector/PDMR Shareholding
2nd Jan 202410:57 amRNSTotal Voting Rights
15th Dec 20235:10 pmRNSHolding(s) in Company
14th Dec 20237:00 amRNSTrading Statement
8th Dec 20235:32 pmRNSDirector/PDMR Shareholding
1st Dec 202311:32 amRNSTotal Voting Rights
20th Nov 20236:30 pmRNSPublication of Admission Particulars
3rd Nov 20239:30 amRNSDirector Declaration
2nd Nov 20232:29 pmRNSDirector/PDMR Shareholding
1st Nov 202311:24 amRNSTotal Voting Rights
1st Nov 20239:00 amRNSBlock listing Interim Review
24th Oct 20237:00 amRNSTrading Statement
6th Oct 20235:08 pmRNSDirector/PDMR Shareholding
4th Oct 20231:40 pmRNSDirector/PDMR Shareholding
2nd Oct 20231:34 pmRNSTotal Voting Rights
2nd Oct 20231:33 pmRNSDirector/PDMR Shareholding
26th Sep 20232:10 pmRNSDirector/PDMR Shareholding
1st Sep 20232:30 pmRNSTotal Voting Rights
31st Aug 202310:30 amRNSDirector/PDMR Shareholding
29th Aug 202310:00 amRNSDividend Declaration
29th Aug 20237:00 amRNSHalf-year Report
29th Aug 20237:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.